CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 158 enrolled
Drug / intervention
accelerated hypofractionated radiotherapy (AHF-RT)radiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01278212
NCT01278212N/ACompleted
CompareCT.gov

A Phase II Study of Accelerated Hypofractionated Radiotherapy (AHF-RT) After Breast Conserving Surgery (BCS) in Medically Underserved Patients

University of Louisville·interventional·Posted Jan 17, 2011·Updated Feb 22, 2024

In Brief

A clinical study evaluating accelerated hypofractionated radiotherapy (AHF-RT) for Breast Cancer. Completed, enrolled 158 participants across 1 site.

Detailed Summary

The goal of this study is to explore the safety, effectiveness, quality of life, and cost effectiveness of accelerated hypofractionated radiotherapy (AHF-RT) as treatment after lumpectomy in patients with early stage breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsJames Graham Brown Cancer Center

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 17, 2011
Enrollment StartJan 1, 2011
Primary CompletionJan 27, 2021
TodayJul 2, 2026
Enrollment to primary: 10.1 yearsPosted 15.5 years ago

Interventions

accelerated hypofractionated radiotherapy (AHF-RT)radiation

30 Gy in 5 fractions once a week for 5 weeks, followed by optional boost of 10-16 Gy